Elite Announces New Development and License Agreement with SunGen Pharma LLC
12 juil. 2017 08h31 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., July 12, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
30 mai 2017 08h42 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., May 30, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported positive topline results from pivotal bioequivalence studies...
Elite Announces Development and License Agreement with SunGen Pharma LLC
29 août 2016 08h00 HE
|
Elite Pharmaceuticals, Inc.; SunGen Pharma, LLC
NORTHVALE, N.J., Aug. 29, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...